Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 257

1.

Hoxa5: A Key Player in Development and Disease.

Jeannotte L, Gotti F, Landry-Truchon K.

J Dev Biol. 2016 Mar 25;4(2). pii: E13. doi: 10.3390/jdb4020013. Review.

2.

Clinical significance and prognostic value of Forkhead box A1 expression in human epithelial ovarian cancer.

Wang K, Guan C, Fang C, Jin X, Yu J, Zhang Y, Zheng L.

Oncol Lett. 2018 Apr;15(4):4457-4462. doi: 10.3892/ol.2018.7899. Epub 2018 Jan 29.

3.

The Many Facets of Metzincins and Their Endogenous Inhibitors: Perspectives on Ovarian Cancer Progression.

Escalona RM, Chan E, Kannourakis G, Findlay JK, Ahmed N.

Int J Mol Sci. 2018 Feb 2;19(2). pii: E450. doi: 10.3390/ijms19020450. Review.

4.

Effects of CD44 and E-cadherin overexpression on the proliferation, adhesion and invasion of ovarian cancer cells.

Mao M, Zheng X, Jin B, Zhang F, Zhu L, Cui L.

Exp Ther Med. 2017 Dec;14(6):5557-5563. doi: 10.3892/etm.2017.5259. Epub 2017 Oct 3.

5.

Histology of the Ovary of the Laying Hen (Gallus domesticus).

Apperson KD, Bird KE, Cherian G, Löhr CV.

Vet Sci. 2017 Dec 11;4(4). pii: E66. doi: 10.3390/vetsci4040066.

6.

Observations on the origin of ovarian cortical inclusion cysts in women undergoing risk-reducing salpingo-oophorectomy.

Park KJ, Patel P, Linkov I, Jotwani A, Kauff N, Pike MC.

Histopathology. 2018 Apr;72(5):766-776. doi: 10.1111/his.13444. Epub 2018 Jan 29.

PMID:
29197096
7.

17β-Estradiol sensitizes ovarian surface epithelium to transformation by suppressing Disabled-2 expression.

Vuong NH, Salah Salah O, Vanderhyden BC.

Sci Rep. 2017 Dec 1;7(1):16702. doi: 10.1038/s41598-017-16219-2.

8.

Expression of Cyclooxygenase-1 and 2 in Epithelial Ovarian Cancer: A Clinicopathologic Study.

Khunnarong J, Tangjitgamol S, Manusirivithaya S, Pataradool K, Thavaramara T, Leelahakorn S.

World J Oncol. 2010 Feb;1(1):19-27. doi: 10.4021/wjon2010.02.190w. Epub 2010 Feb 1.

9.

PAX2 maintains the differentiation of mouse oviductal epithelium and inhibits the transition to a stem cell-like state.

Alwosaibai K, Abedini A, Al-Hujaily EM, Tang Y, Garson K, Collins O, Vanderhyden BC.

Oncotarget. 2017 Aug 10;8(44):76881-76897. doi: 10.18632/oncotarget.20173. eCollection 2017 Sep 29.

10.

The miR-200 family in ovarian cancer.

Koutsaki M, Libra M, Spandidos DA, Zaravinos A.

Oncotarget. 2017 Jun 2;8(39):66629-66640. doi: 10.18632/oncotarget.18343. eCollection 2017 Sep 12. Review.

11.

Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts.

Jung S, Allen N, Arslan AA, Baglietto L, Barricarte A, Brinton LA, Egleston BL, Falk RT, Fortner RT, Helzlsouer KJ, Gao Y, Idahl A, Kaaks R, Krogh V, Merritt MA, Lundin E, Onland-Moret NC, Rinaldi S, Schock H, Shu XO, Sluss PM, Staats PN, Sacerdote C, Travis RC, Tjønneland A, Trichopoulou A, Tworoger SS, Visvanathan K, Weiderpass E, Zeleniuch-Jacquotte A, Dorgan JF.

Int J Cancer. 2018 Jan 15;142(2):262-270. doi: 10.1002/ijc.31058. Epub 2017 Oct 4.

PMID:
28921520
12.

Complex Determinants of Epithelial: Mesenchymal Phenotypic Plasticity in Ovarian Cancer.

Klymenko Y, Kim O, Stack MS.

Cancers (Basel). 2017 Aug 9;9(8). pii: E104. doi: 10.3390/cancers9080104. Review.

13.

Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.

Bilyk O, Coatham M, Jewer M, Postovit LM.

Front Oncol. 2017 Jul 5;7:145. doi: 10.3389/fonc.2017.00145. eCollection 2017. Review.

14.

Screening of potentially crucial genes and regulatory factors involved in epithelial ovarian cancer using microarray analysis.

Shi C, Zhang Z.

Oncol Lett. 2017 Jul;14(1):725-732. doi: 10.3892/ol.2017.6183. Epub 2017 May 17.

15.

Kca3.1 Activation Via P2y2 Purinergic Receptors Promotes Human Ovarian Cancer Cell (Skov-3) Migration.

Robles-Martínez L, Garay E, Martel-Gallegos MG, Cisneros-Mejorado A, Pérez-Montiel D, Lara A, Arellano RO.

Sci Rep. 2017 Jun 28;7(1):4340. doi: 10.1038/s41598-017-04292-6.

16.

Therapeutic utility of natural estrogen receptor beta agonists on ovarian cancer.

Liu J, Viswanadhapalli S, Garcia L, Zhou M, Nair BC, Kost E, Rao Tekmal R, Li R, Rao MK, Curiel T, Vadlamudi RK, Sareddy GR.

Oncotarget. 2017 Jul 25;8(30):50002-50014. doi: 10.18632/oncotarget.18442.

17.

Cadherin composition and multicellular aggregate invasion in organotypic models of epithelial ovarian cancer intraperitoneal metastasis.

Klymenko Y, Kim O, Loughran E, Yang J, Lombard R, Alber M, Stack MS.

Oncogene. 2017 Oct 19;36(42):5840-5851. doi: 10.1038/onc.2017.171. Epub 2017 Jun 19.

18.
19.

Heterogeneous Cadherin Expression and Multicellular Aggregate Dynamics in Ovarian Cancer Dissemination.

Klymenko Y, Johnson J, Bos B, Lombard R, Campbell L, Loughran E, Stack MS.

Neoplasia. 2017 Jul;19(7):549-563. doi: 10.1016/j.neo.2017.04.002. Epub 2017 Jun 9.

20.

Ovarian cancer stem cells: still an elusive entity?

Lupia M, Cavallaro U.

Mol Cancer. 2017 Mar 20;16(1):64. doi: 10.1186/s12943-017-0638-3. Review.

Supplemental Content

Support Center